Finance Watch: Aileron, Talaris, Frequency And The Search For Strategic Alternatives
Job Cuts Continue As Programs Fail, Cash Dwindles
Public Company Edition: Aileron, Talaris and Frequency said they will reduce expenses and seek options for maximizing shareholder returns under tough stock market conditions. However, CureVac and Supernus are among firms recently able to access new cash – $250m and $150m, respectively.
